key: cord-1030147-mdtejz8b
authors: De Vriese, An S.; Reynders, Marijke
title: IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis
date: 2020-06-05
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2020.05.009
sha: e704a2d73c02f2fb4e0ac56d7b0da2c2aa20b6f6
doc_id: 1030147
cord_uid: mdtejz8b

nan

To the editor:

Quarantining dialysis patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a logistical challenge. Appropriately identifying noninfectiousness in patients is essential to safely lift quarantine measures. Serological test are used to establish previous infection with SARS-CoV-2, but the extent to which antibody positivity translates to actual immunity is currently unknown.(1) Hemodialysis patients are known to have impaired humoral immune responses to vaccination and infection, and it is uncertain whether hemodialysis patients mount an effective antibody response against SARS-CoV-2.

Of our 282 maintenance hemodialysis patients, 7 developed SARS-CoV-2 infection between March 14 and April 7, 2020. All patients displayed symptoms of coronavirus disease 2019 (COVID-19) and tested positive for SARS-CoV-2 RNA on a nasopharyngeal swab on the day of symptom onset. Three patients died (at days 6, 11, and 36), 1 patient is currently still ventilated, and 3 patients recovered clinically. Longitudinal serum sampling and nasopharyngeal swabs were performed in 6 of 7 patients (1 patient died before follow-up samples were obtained).

Overall IgG seroconversion rate was 100% and occurred in the second week after symptom onset. Antibody titer plateaued during the third week ( Figure 1A ). Virus persisted in respiratory samples of non-survivors until death. In survivors, nucleic acid conversion time, defined as the interval from symptom onset to first negative RT-PCR, was 34, 37, 37, and 44 days. Cycle threshold values, an inverse measure of nucleic acid concentration, were lowest in the first week of infection and remained relatively stable thereafter ( Figure 1B ).

In conclusion, maintenance hemodialysis patients are able to mount an antibody response against SARS-CoV-2 that is similar in intensity and timing to that of the nondialysis population. However, anti-SARS-CoV-2 IgG antibodies appeared weeks before the actual clearance of the virus from the upper airways, suggesting that these antibodies are not neutralizing. Viral shedding persisted for more than 5 weeks after symptom onset in survivors. Although viral shedding does not necessarily equal infectiousness, 2 awaiting negative RT-PCR testing on at least two sequential samples before lifting quarantine in hemodialysis patients is the prudent approach. 

Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?

Virological assessment of hospitalized patients with COVID-2019

SARS-CoV-2 specific antibody responses in COVID-19 patients

Peer Review: Received May 19, 2020. Direct editorial input from an Associate Editor and a Deputy Editor. Accepted in revised form May 29, 2020.